Patent Assignment
Reel/Frame 065058/0096
Assignment of Assignor's Interest
Recorded: 2023-09-28
Pages: 3
Assignor
ULTRAHUMAN FOUR LIMITED
Executed: 2023-09-26
Assignee
CENTESSA PHARMACEUTICALS (UK) LIMITED
3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT, UNITED KINGDOM
Covered Properties
(3)
Anti-CD47 Antibody Molecules
Method of Using Anti-CD47 Antibody Molecules
Treating Cancer Using Nucleic Acid Encoding an Anti-CD47 Binding Agent
Application:
17/849,101 →
Publication:
US 2022/0332819
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 21, 2019
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 050117/0304 →
Assignment of Assignor's Interest
Jun 30, 2020
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 053089/0938 →
Security Interest
Oct 4, 2021
From: APCINTEX LIMITED; JANPIX LIMITED; CAPELLA BIOSCIENCE LTD; LOCKBODY THERAPEUTICS LTD
To: COCOON SA LLC
Reel/Frame 057710/0082 →
Change of Registered Office Address
Mar 2, 2022
From: ULTRAHUMAN FOUR LIMITED
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 059304/0038 →
Assignment of Assignor's Interest
Nov 3, 2022
From: FINALY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 061648/0733 →
Change of Address
Nov 3, 2022
From: ULTRAHUMAN FOUR LIMITED
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 061879/0735 →
Corrective Assignment to Correct the Assignor's Name Previously Recorded at Reel: 061648 Frame: 0733. Assignor(S) Hereby Confirms the Assignment .
Dec 14, 2022
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 062119/0110 →
Security Interest
Dec 31, 2024
From: CENTESSA PHARMACEUTICALS (UK) LIMITED
To: OXFORD FINANCE LLC
Reel/Frame 069708/0039 →
Release of Security Interest
Jun 24, 2026
From: OXFORD FINANCE LLC
To: CENTESSA PHARMACEUTICALS (UK) LIMITED
Reel/Frame 075069/0879 →